Skip over global navigation links
U.S. Department of Health and Human Services
HHS funds drug to treat severe infections and prevent cytokine storm.  Therapy modulates inflammatory response and may help treatment of “flesh-eating bacteria”and biothreats.  Learn More. 

State Coordination



More about state coordination...

In the Spotlight

    HHS contracts with Mapp Biopharmaceutical to develop Ebola drug. Work will accelerate drug development and testing. Learn More.

News & Events

Retrieving Data
  • This page last reviewed: September 29, 2014